We also observed this phenomenon in patient tissue, where more differentiated, GFAP+ Ki67low vimentinlow, tumour regions stained positive for phosphorylated ERK1/2, highlighting an active process during disease progression. This evidence concerns the gene GFAP and neoplasm.